Owkin has announced a new multi-year partnership with Sanofi to co-develop next-generation biopharma agents using Owkin's AI technology. This collaboration builds on their existing relationship, initially established in 2021, and aims to enhance drug research and development efficiencies.
Company Information
Company
Owkin
Location
Paris, Ile-de-France, France
About
Owkin is a TechBio company that combines the best of human and artificial intelligence to find the right treatment for every patient. They are on a mission to understand complex biology, derive new multimodal biomarkers through AI, identify precision therapeutics, de-risk and accelerate clinical trials, and develop diagnostics using AI trained on world-class patient data through privacy-enhancing technologies.